AcrySof™ IQ PanOptix™ UV IOL TFAT00 (REF TFAT00.100)Recalls & reported problems
Alcon Laboratories, Inc. · The AcrySof® IQ PanOptix® UV Absorbing Trifocal intraocular lenses (IOLs) are ultraviolet absorbing foldable multifocal IOLs · Class 3 · Implant
All models of AcrySof IQ PanOptix UV IOL (28)
Data updated Oct 16, 2026 from official FDA records · Editorial policy
- Adverse event reports
- 2
- Deaths reported
- 0
- Injuries reported
- 2
- Recalls naming it
- 0
Summary
The FDA's MAUDE database contains 2 adverse event reports that list this exact device (DI 00380652429511), received between May 23, 2023 and Dec 12, 2024 — classified as 2 injuries.
The most frequently reported specific device problem is “Material Opacification” (1 report).
Reports come from manufacturers, hospitals and patients and are not verified by the FDA. A report does not prove the device caused the event, and counts can't be used to compare devices or estimate failure rates. What reports can and can't tell you · How this data works · Data updated Oct 16, 2026.
Reports received per month
Most reported problems
Device problems
- Adverse Event Without Identified Device or Use Problem1
- Material Opacification1
Patient problems
- Blurred Vision2
- Dry Eye(s)1
- Halo1
- Irritability1
- Visual Disturbances1
Recent adverse event reports
The 2 most recent of 2 reports, in the reporter's own words as published by the FDA.
InjuryDec 12, 2024Adverse Event Without Identified Device or Use Problem; Adverse Event Without Identified Device or Use Problem
A FACILITY REPRESENTATIVE REPORTED THAT FOLLOWING AN INTRAOCULAR LENS (IOL) IMPLANT PROCEDURE, THE PATIENT EXPERIENCED BLURRED VISION. THE IOL WAS EXCHANGED FOR ANOTHER LENS 1 MONTH FOLLOWING THE INITIAL PROCEDURE. CLINICAL REASON FOR THE EXPLANT WAS MENTIONED AS MECHANICAL COMPLICATION.
Patient problems: Blurred Vision
MAUDE report 20914187 ↗InjuryMay 23, 2023Material Opacification; Material Opacification
A NON-HEALTH CARE PROFESSIONAL REPORTED FOLLOWING THE INTRAOCULAR LENS IMPLANTATION THE PATIENT HAD EXPRESSED SOME CONCERNS AND ISSUES ABOUT THE LENS THAT WAS IMPLANTED. THE PATIENT STATED MUST USE READERS, SINCE THE PATIENT CAN'T SEE UP CLOSE VERY GOOD, IT WAS LIKE THE LENS HAD A CLOUD OVER IT. THE PATIENT COULD SEE BETTER FROM THE LEFT EYE WITH A CONTACT LENS. IT SEEMS TO DO ALL OF THE WORK NOW. AT NIGHT, THERE IS A "HALO" OR "STARBURST" OF LIGHT WITH THE MULTI-FOCAL LENS TO WHERE THE PATIENT COULD NOT SEE OUT OF IT. THE PATIENT WAS CONSTANTLY USING EYE DROPS IN THE RIGHT EYE LIKE NEVER BEFORE, BECAUSE IT ALWAYS FEELS DRY AND IRRITATED, PRETTY MUCH EVERY DAY. SOMETIMES, IT'S LIKE THERE IS SOMETHING IN THE EYE, AS WHEN A CONTRACT LENS GETS CURLED UP IN THE TOP OF THE EYE BY ACCIDENT. IT IS VERY UNCOMFORTABLE MOST DAYS. THE PATIENT RECENTLY HAD THE YAG SURGERY ON RIGHT EYE REALLY DIDN'T NOTICE A DIFFERENCE AND STILL HAVE TO WEAR READERS TO SEE CLOSE UP. ADDITIONAL INFORMATION HAS BEEN REQUESTED.
Patient problems: Blurred Vision; Dry Eye(s); Halo; Irritability; Visual Disturbances
MAUDE report 16982149 ↗
Other Lens, multifocal intraocular devices
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular144 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular1 recall66 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular113 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular112 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular110 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular107 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular104 reports
- Clareon™ CNA0T0Alcon Laboratories, Inc. · Lens, multifocal intraocular93 reports
Sources and updates
- Device record: FDA GUDID, file dated Oct 13, 2026 · View this device in AccessGUDID ↗
- Adverse event reports: FDA MAUDE, file dated Oct 14, 2026 · each report above links to its original FDA record
- Recalls: FDA Medical Device Recalls, file dated Oct 16, 2026
- Page last rebuilt: Oct 16, 2026. Data downloaded through openFDA, which notes it is not validated for clinical or regulatory use.
How reports and recalls are matched · Editorial policy · Report an error on this page